Get access

Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection

Authors


Professor László Vécsei, Director, Department of Neurology University of Szeged, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, Semmelweis u., 6.H-6725 Szeged, Hungary. Tel.: +36(62)545 351, 545 348; Fax: +36(62)545 597; E-mail: vecsei@nepsy.szote.u-szeged.hu

Abstract

Although the number of available therapeutic approaches in Parkinson's disease (PD) is steadily increasing the search for effective neuroprotective agent is continuing. Such research is directed at influencing the key steps in the pathomechanism: the mitochondrial dysfunction, the oxidative stress, the neuroinflammatory processes and the final common apoptotic pathway. Earlier-developed symptomatic therapies were implicated to be neuroprotective, and promising novel disease modifying approaches were brought into the focus of interest. The current review presents a survey of our current knowledge relating to the pathomechanism of PD and discusses the putative neuroprotective therapy.

Ancillary